Ultimovacs ASA
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy (NCT04701021) | Ultimovacs ASA | 2021-02-17 |
| UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma (NCT04382664) | Ultimovacs ASA | 2020-05-27 |
| UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma (NCT03538314) | Ultimovacs ASA | 2018-07-09 |
Track Ultimovacs ASA automatically
Every clearance here is in the API, with alerts when new ones post.